Section Arrow
AEON.NYSE-M
- AEON Biopharma
Quotes are at least 15-min delayed:2026/08/11 17:12 EDT
After Hours
Last
 0.2712
-0.0018 (-0.66%)
Bid
0.273
Ask
0.2912
High 0.2818 
Low 0.2707 
Volume 178 
Regular Hours (Closed)
Last
 0.273
-0.0044 (-1.59%)
Day High 
0.2817 
Prev. Close
0.2774 
1-M High
0.4849 
Volume 
194.49K 
Bid
0.273
Ask
0.2912
Day Low
0.2658 
Open
0.2774 
1-M Low
0.2222 
Market Cap 
13.55M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.28 
20-SMA 0.28 
50-SMA 0.52 
52-W High 1.45 
52-W Low 0.2222 
Exchange NYSE-M 
Valuation Estimation
EPS (Current/Estimated)
-6.52/-0.69
Enterprise Value
49.05M
Balance Sheet
Book Value Per Share
-0.34
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
MREOMereo BioPharma Group plc0.3055+0.0331+12.15%-- 
After Hours 0.325 +0.0195 +6.38%
TENXTenax Therapeutics1.62+0.245+17.82%-- 
After Hours 1.64 +0.02 +1.23%
PDSBPDS Biotechnology Corp0.2568-0.4743-64.87%-- 
After Hours 0.253 -0.0038 -1.48%
ABCLAbCellera Biologics9.76+0.42+4.50%-- 
After Hours 9.3185 -0.4415 -4.52%
DRMADermata Therapeutics Inc1.08-0.04-3.57%-- 
After Hours 1.5415 +0.4615 +42.73%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.